CoE-applicant from the Institute for cancer research to final round
H.A. Stenmark - proposed CoE director
In December 2006, between five and ten new centres of excellence will be selected by the Research Council. 26 of the total of 98 research groups that have applied for CoE-status from 2007 have reached the final selection round. Among the finalists is the application from the "Centre for Cancer Biomedicine" at Norwegian Radium Hospital, with Harald A. Stenmark as proposed CoE director. At present, there are 13 established Norwegian Centres of Excellence in all fields of science.
The Centres of Excellence (CoE) scheme, which is initiated by the Research Council of Norway, has the intention to bring more Norwegian researchers and research groups up to a high international standard. The centres are devoted to long-term, basic research.
From major journals, first or last author from the Institute for Cancer Research
Alampi MM, Kozlíková M, Mariangeli M, Civita S, Delcanale P, Mussini A, Diaspro A, Bianchini P, Weyergang A, Skarpen E, Berg K, Viappiani C, Abbruzzetti S, Selbo PK(2025) Light-enhanced cytotoxicity and intracellular trafficking of the PD-L1-targeting photoimmunoconjugate EITC-atezolizumab Biomed Pharmacother, 191, 118550(in press) DOI 10.1016/j.biopha.2025.118550, PubMed 40946581
Eggebø MS, Heinzelbecker J, Palashati H, Chandler N, Tran TT, Li Y, Yang W, Laos M, Blaas I, Rustad EH, Bollineni RC, Delic-Sarac M, Lund-Johansen F, Nielsen MM, Olweus J(2025) TCR-engineered T cells targeting a shared β-catenin mutation eradicate solid tumors Nat Immunol(in press) DOI 10.1038/s41590-025-02252-1, PubMed 40866620
Ullern A, Holm K, Andresen NK, Røssevold AH, Bang C, Naume B, Hov JR, Kyte JA(2025) Gut microbiota diversity is prognostic in metastatic hormone receptor-positive breast cancer patients receiving chemotherapy and immunotherapy Mol Oncol(in press) DOI 10.1002/1878-0261.70117, PubMed 40852937
Nie X, Sun Y, van Dijk DPJ, Deng M, Brecheisen R, Wang Z, Xia Q, Olde Damink SMW, Rensen SS(2025) Loss of Skeletal Muscle Mass Is Associated With Reduced Cytotoxic T Cell Abundance and Poor Survival in Advanced Lung Cancer J Cachexia Sarcopenia Muscle, 16(5), e70063 DOI 10.1002/jcsm.70063, PubMed 40931431
Alampi MM, Kozlíková M, Mariangeli M, Civita S, Delcanale P, Mussini A, Diaspro A, Bianchini P, Weyergang A, Skarpen E, Berg K, Viappiani C, Abbruzzetti S, Selbo PK(2025) Light-enhanced cytotoxicity and intracellular trafficking of the PD-L1-targeting photoimmunoconjugate EITC-atezolizumab Biomed Pharmacother, 191, 118550(in press) DOI 10.1016/j.biopha.2025.118550, PubMed 40946581
Ølnes ÅS, Teigen M, Laerdahl JK, Leren TP, Strøm TB, Bjune K(2025) Correction: Variants in the CETP gene affect levels of HDL cholesterol by reducing the amount, and not the specific lipid transfer activity, of secreted CETP PLoS One, 20(9), e0332400 DOI 10.1371/journal.pone.0332400, PubMed 40938802